ResMed Inc. (ASX:RMD)

ResMed Revenue

ResMed had revenue of $1.29B USD in the quarter ending March 31, 2025, with 7.92% growth. This brings the company's revenue in the last twelve months to $5.02B, up 9.54% year-over-year. In the fiscal year ending June 30, 2024, ResMed had annual revenue of $4.69B with 10.95% growth.

• Revenue (ttm): $5.02B
• Revenue Growth: +9.54%
• P/S Ratio: 7.13
• Revenue / Employee: $503.16K
• Employees: 9,980
• Market Cap: 57.40B AUD

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	4.69B	462.30M	10.95%
Jun 30, 2023	4.22B	644.87M	18.02%
Jun 30, 2022	3.58B	381.30M	11.93%
Jun 30, 2021	3.20B	239.81M	8.11%
Jun 30, 2020	2.96B	350.44M	13.44%